ATE534738T1 - Mir-126-regulierte gene und pfade als ziele für therapeutische interventionen - Google Patents

Mir-126-regulierte gene und pfade als ziele für therapeutische interventionen

Info

Publication number
ATE534738T1
ATE534738T1 AT07871691T AT07871691T ATE534738T1 AT E534738 T1 ATE534738 T1 AT E534738T1 AT 07871691 T AT07871691 T AT 07871691T AT 07871691 T AT07871691 T AT 07871691T AT E534738 T1 ATE534738 T1 AT E534738T1
Authority
AT
Austria
Prior art keywords
mir
pathways
targets
regulated genes
therapeutic interventions
Prior art date
Application number
AT07871691T
Other languages
English (en)
Inventor
Andreas G Bader
Mike Byrom
Charles D Johnson
David Brown
Original Assignee
Asuragen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asuragen Inc filed Critical Asuragen Inc
Application granted granted Critical
Publication of ATE534738T1 publication Critical patent/ATE534738T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT07871691T 2006-12-08 2007-12-10 Mir-126-regulierte gene und pfade als ziele für therapeutische interventionen ATE534738T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86929506P 2006-12-08 2006-12-08
US93956307P 2007-05-22 2007-05-22
PCT/US2007/087033 WO2008073921A2 (en) 2006-12-08 2007-12-10 Mir-126 regulated genes and pathways as targets for therapeutic intervention

Publications (1)

Publication Number Publication Date
ATE534738T1 true ATE534738T1 (de) 2011-12-15

Family

ID=39512447

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07871691T ATE534738T1 (de) 2006-12-08 2007-12-10 Mir-126-regulierte gene und pfade als ziele für therapeutische interventionen

Country Status (5)

Country Link
EP (1) EP2104736B1 (de)
AT (1) ATE534738T1 (de)
AU (1) AU2007333108A1 (de)
CA (1) CA2671296A1 (de)
WO (1) WO2008073921A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5654352B2 (ja) 2007-11-09 2015-01-14 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム ｍｉＲ−１５ファミリーのマイクロＲＮＡによる心筋細胞生存及び心臓修復の調節
US20110172293A1 (en) * 2008-07-08 2011-07-14 Fish Jason E Methods and Compositions for Modulating Angiogenesis
WO2010019574A1 (en) * 2008-08-11 2010-02-18 The Board Of Regents Of The University Of Texas System A micro-rna that promotes vascular integrity and uses thereof
AU2010243276B2 (en) 2009-04-30 2016-09-15 Fondazione Telethon Ets Gene vector
EP2327781A1 (de) 2009-11-27 2011-06-01 RWTH Aachen Mikro-RNA und Gewebereparatur
WO2013066368A1 (en) * 2011-10-03 2013-05-10 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Use of mirna 126 to produce hematopoietic stem cells
US20150190532A1 (en) 2012-04-04 2015-07-09 The Trustees Of Columbia University In The City Of New York Smooth muscle specific inhibition for anti-restenotic therapy
US9163235B2 (en) 2012-06-21 2015-10-20 MiRagen Therapeutics, Inc. Inhibitors of the miR-15 family of micro-RNAs
CN104830858A (zh) * 2015-03-05 2015-08-12 中国人民解放军第四军医大学 一种与浆液性卵巢癌发生发展机制相关的microRNA分子及其应用
CN113101368B (zh) * 2020-01-13 2022-10-21 中国医学科学院肿瘤医院 Slc7a8在食管鳞癌辅助诊断、癌前预警和靶向治疗中的应用
CN112760375A (zh) * 2020-08-04 2021-05-07 佛山科学技术学院 一种特征miRNA表达谱组合及子宫内膜癌早期预测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1592791A2 (de) * 2003-02-10 2005-11-09 National Institute of Advanced Industrial Science and Technology Regulation der genexpression durch dna-interferenz
CA2857881A1 (en) * 2004-11-12 2006-12-28 Asuragen, Inc. Methods and compositions involving mirna and mirna inhibitor molecules

Also Published As

Publication number Publication date
EP2104736A2 (de) 2009-09-30
WO2008073921A3 (en) 2009-02-26
AU2007333108A1 (en) 2008-06-19
EP2104736B1 (de) 2011-11-23
CA2671296A1 (en) 2008-06-19
WO2008073921A2 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
ATE534738T1 (de) Mir-126-regulierte gene und pfade als ziele für therapeutische interventionen
WO2008073919A3 (en) Mir-20 regulated genes and pathways as targets for therapeutic intervention
WO2008036741A3 (en) Mir-200 regulated genes and pathways as targets for therapeutic intervention
WO2008154333A3 (en) Mir-34 regulated genes and pathways as targets for therapeutic intervention
WO2009086156A3 (en) Mir-10 regulated genes and pathways as targets for therapeutic intervention
WO2009070805A3 (en) Mir-124 regulated genes and pathways as targets for therapeutic intervention
WO2008073920A3 (en) Mir-21 regulated genes and pathways as targets for therapeutic intervention
WO2008085797A8 (en) miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
WO2009154835A3 (en) Compositions and methods related to mir-16 and therapy of prostate cancer
ATE535807T1 (de) Gensignaturen
WO2008036776A3 (en) Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
MX2009002936A (es) Biomarcadores de la modulacion de objetivo, eficacia, diagnostico, y/o pronostico para los inhibidores de raf.
CY1121198T1 (el) Αντινοημaτικα μορια και μεθοδοι για την θεραπεια παθολογιων
WO2008073922A3 (en) Functions and targets of let-7 micro rnas
MX2009010439A (es) Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama.
ATE527385T1 (de) Mit tumoren assoziierte genetische variationen
CA2812115C (en) Epigenetic markers of colorectal cancers and diagnostic methods using the same
WO2010045318A3 (en) Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
WO2009059318A3 (en) Genes and polymorphisms associated with amd
WO2010062960A3 (en) METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
WO2009044899A1 (ja) 細胞の増殖を制御する核酸
WO2009114681A3 (en) Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy
WO2010031056A3 (en) Methods and compositions for modulating ire1, src, and abl activity
WO2009086215A3 (en) Pathway analysis of cell culture phenotypes and uses thereof
EA201390704A1 (ru) Соединения, ингибирующие металлоферменты